References
- ChobanianAVBakrisGLBlackHRSeventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressureHypertension20034261206125214656957
- ManciaGDe BackerGDominiczakA2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)J Hypertens20072561105118717563527
- KawaiTOhishiMKamideKThe impact of visit-to-visit variability in blood pressure on renal functionHypertens Res201135223924322011685
- LeeHTLimY-HKimBKThe relationship between ambulatory arterial stiffness index and blood pressure variability in hypertensive patientsKorean Circ J201141523524021731563
- MasugataHSendaSMuraoKVisit-to-visit variability in blood pressure over a 1-year period is a marker of left ventricular diastolic dysfunction in treated hypertensive patientsHypertens Res201134784685021562506
- MuntnerPShimboDTonelliMReynoldsKArnettDKOparilSThe relationship between visit-to-visit variability in systolic blood pressure and all-cause mortality in the general population findings from NHANES III, 1988 to 1994Hypertension201157216016621200000
- RothwellPMHowardSCDolanEPrognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertensionLancet2010375971889590520226988
- Suchy-DiceyAMWallaceERElkindMSBlood pressure variability and the risk of all-cause mortality, incident myocardial infarction, and incident stroke in the cardiovascular health studyAm J Hypertens201326101210121723744496
- ConwayJBoonNDaviesCJonesJVSleightPNeural and humoral mechanisms involved in blood pressure variabilityJ Hypertens1984222032086398335
- ManciaGParatiGPomidossiGCasadeiRDi RienzoMZanchettiAArterial baroreflexes and blood pressure and heart rate variabilities in humansHypertension1986821471533080371
- OkadaHFukuiMTanakaMVisit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetesAtherosclerosis2012220115515922100253
- SegaRCesanaGBombelliMSeasonal variations in home and ambulatory blood pressure in the PAMELA populationJ Hypertens19981611158515929856358
- MatsuiYIshikawaJEguchiKShibasakiSShimadaKKarioKMaximum value of home blood pressure a novel indicator of target organ damage in hypertensionHypertension20115761087109321536993
- UshigomeEFukuiMHamaguchiMThe coefficient variation of home blood pressure is a novel factor associated with macroalbuminuria in type 2 diabetes mellitusHypertens Res201134121271127521814212
- KikuyaMOhkuboTMetokiHDay-by-day variability of blood pressure and heart rate at home as a novel predictor of prognosis the Ohasama studyHypertension20085261045105018981332
- RothwellPMLimitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertensionLancet2010375971893894820226991
- RothwellPHowardSDolanEASCOT-BPLA and MRC Trial InvestigatorsEffects of beta blockers and calcium-channel blockers on within-individual variability in blood pressure and risk of strokeLancet Neurol20109546948020227347
- FukuiMUshigomeETanakaMHome blood pressure variability on one occasion is a novel factor associated with arterial stiffness in patients with type 2 diabetesHypertens Res201236321922523096230
- SchutteRThijsLLiuY-PWithin-subject blood pressure level – not variability – predicts fatal and nonfatal outcomes in a general populationHypertension20126051138114723071126
- MasudaSTamuraKWakuiHEffects of angiotensin II type 1 receptor blocker on ambulatory blood pressure variability in hypertensive patients with overt diabetic nephropathyHypertens Res2009321195095519713965
- ParatiGDolanELeyLSchumacherHImpact of antihypertensive combination and monotreatments on blood pressure variability: assessment by old and new indices. Data from a large ambulatory blood pressure monitoring databaseJ Hypertens20143261326133324759124
- ShigenagaA-ITamuraKDejimaTEffects of angiotensin II type 1 receptor blocker on blood pressure variability and cardiovascular remodeling in hypertensive patients on chronic peritoneal dialysisNephron Clin Pract20091121c31c4019342867
- ParkJBSungK-CKangSMChoEJSafety and efficacy of fimasar-tan in patients with arterial hypertension (Safe-KanArb Study)Am J Cardiovasc Drugs2013131475623344912
- KimCKimMYKangDRKimJYParkJBK-MetS study investigatorsThe efficacy of fimasartan for cardiovascular events and metabolic syndrome (K-MetS Study): Rationale, design and participant characteristicsPulse (Basel)201413–417718526587436
- AsmarRKhabouthJTopouchianJEl FeghaliRMattarJValidation of three automatic devices for self-measurement of blood pressure according to the International Protocol: The Omron M3 Intellisense (HEM-7051-E), the Omron M2 Compact (HEM 7102-E), and the Omron R3-I Plus (HEM 6022-E)Blood Pres Monit20101514954
- CicconettiPCacciafestaMMiglioriMInfluence of sex and age on blood pressure variabilityArch Gerontol Geriatr200030322523610867166
- ParatiGOchoaJEBiloGBlood pressure variability, cardiovascular risk, and risk for renal disease progressionCurr Hypertens Rep201214542143122903810
- JohanssonJKNiiranenTJPuukkaPJJulaAMPrognostic value of the variability in home-measured blood pressure and heart rate the Finn-Home StudyHypertension201259221221822215704
- IchiharaAKaneshiroYTakemitsuTSakodaMEffects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patientsJ Hum Hypertens2006201078779416810279
- ZhangYAgnolettiDSafarMEBlacherJEffect of antihypertensive agents on blood pressure variability: the Natrilix SR versus candesartan and amlodipine in the reduction of systolic blood pressure in hypertensive patients (X-CELLENT) StudyHypertension201158215516021747047
- NissenSETuzcuEMLibbyPEffect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trialJAMA2004292182217222515536108
- YoshidaHAkasakaHSaitohSShimamotoKMiuraTComparative effects of telmisartan and valsartan as add-on agents for hypertensive patients with morning blood pressure insufficiently controlled by amlodipine monotherapyHypertens Res201337322523124108237
- PringleEPhillipsCThijsLSystolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive populationJ Hypertens200321122251225714654744